Samuel Lévy
About
Samuel Lévy is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery.
According to data from OpenAlex, Samuel Lévy has authored 190 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Cardiology and Cardiovascular Medicine, 27 papers in Molecular Biology and 21 papers in Surgery. Recurrent topics in Samuel Lévy's work include Cardiac Arrhythmias and Treatments (84 papers), Atrial Fibrillation Management and Outcomes (59 papers) and Cardiac electrophysiology and arrhythmias (52 papers). Samuel Lévy is often cited by papers focused on Cardiac Arrhythmias and Treatments (84 papers), Atrial Fibrillation Management and Outcomes (59 papers) and Cardiac electrophysiology and arrhythmias (52 papers). Samuel Lévy collaborates with scholars based in France, United States and Italy. Samuel Lévy's co-authors include Harry J.G.M. Crijns, J. Craig Venter, Sridhar Hannenhalli, Pauline C. Ng, Robby Nieuwlaat, Günter Breithardt, Martin H. Prins, Sarah S. Murray, Axel Haverich and Luigi Tavazzi and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.
In The Last Decade
Samuel Lévy
181 papers receiving 9.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Samuel Lévy France | 45 | 6.4k | 2.1k | 1.1k | 784 | 775 | 190 | 10.3k | ||
| Guohua Pan United States | 30 | 6.6k 1.0× | 5.4k 2.5× | 458 0.4× | 119 0.2× | 517 0.7× | 55 | 14.4k | ||
| Paolo Emilio Puddu Italy | 42 | 3.0k 0.5× | 1.1k 0.5× | 159 0.1× | 119 0.2× | 1.1k 1.5× | 356 | 6.8k | ||
| Paul Cullen Germany | 50 | 1.8k 0.3× | 1.7k 0.8× | 536 0.5× | 125 0.2× | 2.8k 3.6× | 141 | 8.5k | ||
| Annalisa Santucci Italy | 49 | 1.8k 0.3× | 3.3k 1.6× | 500 0.5× | 425 0.5× | 1.2k 1.5× | 303 | 10.4k | ||
| Paul J. Simpson United States | 35 | 629 0.1× | 2.0k 0.9× | 397 0.4× | 345 0.4× | 611 0.8× | 94 | 5.6k | ||
| Kathleen F. Kerr United States | 32 | 528 0.1× | 3.1k 1.5× | 779 0.7× | 586 0.7× | 344 0.4× | 113 | 6.4k | ||
| Chang Yu United States | 46 | 985 0.2× | 3.2k 1.5× | 830 0.8× | 1.4k 1.7× | 914 1.2× | 155 | 8.7k | ||
| Wolfgang Lieb Germany | 44 | 1.9k 0.3× | 1.4k 0.7× | 430 0.4× | 50 0.1× | 737 1.0× | 193 | 6.3k | ||
| Scott J. Cameron United States | 35 | 705 0.1× | 3.9k 1.8× | 305 0.3× | 519 0.7× | 436 0.6× | 125 | 6.5k | ||
| Amy P. Hsu United States | 44 | 1.0k 0.2× | 1.6k 0.7× | 1.1k 1.0× | 102 0.1× | 1.1k 1.4× | 149 | 8.0k |
Countries citing papers authored by Samuel Lévy
Since
Specialization
Citations
This map shows the geographic impact of Samuel Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Lévy more than expected).
Fields of papers citing papers by Samuel Lévy
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Samuel Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Lévy. The network helps show where Samuel Lévy may publish in the future.
Co-authorship network of co-authors of Samuel Lévy
This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Lévy. A scholar is included among the top collaborators of Samuel Lévy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Lévy. Samuel Lévy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lévy, Samuel. (2018). Bundle branch blocks and/or hemiblocks complicating acute myocardial ischemia or infarction. Journal of Interventional Cardiac Electrophysiology. 52(3). 287–292.
2.
Pang, Andy Wing Chun, Jeffrey R. MacDonald, Dalila Pinto, et al.. (2010). Towards a comprehensive structural variation map of an individual human genome. Genome biology. 11(5). R52–R52.
3.
Harismendy, Olivier, Pauline C. Ng, Robert L. Strausberg, et al.. (2009). Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome biology. 10(3). R32–R32.
4.
Dahl, Morten, Russell P. Bowler, Klaus Juul, et al.. (2008). Superoxide Dismutase 3 Polymorphism Associated with Reduced Lung Function in Two Large Populations. American Journal of Respiratory and Critical Care Medicine. 178(9). 906–912.
5.
Nieuwlaat, Robby, S. Bertil Olsson, Gregory Y.H. Lip, et al.. (2007). Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. American Heart Journal. 153(6). 1006–1012.
6.
Nieuwlaat, Robby, Alessandro Capucci, A. John Camm, et al.. (2005). Atrial fibrillation management: a prospective survey in ESC Member Countries. European Heart Journal. 26(22). 2422–2434.
7.
Lévy, Samuel, A. John Camm, Sanjeev Saksena, et al.. (2003). International Consensus on Nomenclature and Classification of Atrial Fibrillation: A Collaborative Project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Journal of Cardiovascular Electrophysiology. 14(4). 443–445.
8.
Fuster, Valentı́n, Lars Rydén, Richard Asinger, et al.. (2001). Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. European Heart Journal. 22(20). 1852–1923.
9.
Maixent, Jean‐Michel, et al.. (2000). Inhibition of Na,K‐ATPase by External Electrical Cardioversion in a Sheep Model of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 11(4). 439–445.
10.
Lévy, Samuel. (1998). Restoring Sinus Rhythm in Atrial Fibrillation: Electrical or Pharmacological Cardioversion. Annals of Noninvasive Electrocardiology. 3(2). 109–114.
11.
Lévy, Samuel. (1998). AMIODARONE IN ATRIAL FIBRILLATION. International Journal of Clinical Practice. 52(6). 429–431.
12.
Lévy, Samuel, et al.. (1998). Gene organization and chromosome location of the neural-specific RNA binding protein Elavl4. Gene. 208(2). 139–145.
13.
Lévy, Samuel, Philippe Ricard, Chu‐Pak Lau, et al.. (1997). Multicenter Low Energy Transvenous Atrial Defibrillation (XAD) Trial Results in Different Subsets of Atrial Fibrillation. Journal of the American College of Cardiology. 29(4). 750–755.
14.
Daubert, Jean‐Claude, Samuel Lévy, & J L Medvedowsky. (1994). [Recommendations for good practice of intracavitary techniques for diagnosis and treatment of cardiac arrhythmia. Diagnostic electrophysiology; interventional electrophysiology; permanent cardiac stimulation; implantable automatic defibrillators].. PubMed. 87(9). 1213–24.
15.
Lévy, Samuel. (1994). Differentiating SVT from VT-- a Personal Viewpoint. European Heart Journal. 15(suppl A). 31–38.
16.
Waldo, Albert L., Masood Akhtar, David G. Benditt, et al.. (1988). Appropriate electrophysiologic study and treatment of patients with the Wolff-Parkinson-White syndrome. Journal of the American College of Cardiology. 11(5). 1124–1129.
17.
Lévy, Samuel, et al.. (1988). High energy transcatheter cardioversion of chronic atrial fibrillation. Journal of the American College of Cardiology. 12(2). 514–518.
18.
Saadjian, A, et al.. (1988). Long‐Term Follow‐Up of Patients Treated with VVI Pacing and Sequential Pacing with Special Reference to VA Retrograde Conduction. Pacing and Clinical Electrophysiology. 11(11). 1929–1934.
19.
EVANS, GRIFFITH, Melvin M. Scheinman, Melvin M. Scheinman, et al.. (1987). The Percutaneous Cardiac Mapping and Ablation Registry*: Summary of Results. Pacing and Clinical Electrophysiology. 10(6). 1395–1399.
20.
Lévy, Samuel, Azorides R. Morales, & Robert J. Boucek. (1973). Acute thromboembolism associated with dissecting aneurysm of the aorta. Journal of Thoracic and Cardiovascular Surgery. 66(1). 82–86.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Guohua Pan Breakdown of academic impact, for papers by Paolo Emilio Puddu Breakdown of academic impact, for papers by Paul Cullen Breakdown of academic impact, for papers by Annalisa Santucci Breakdown of academic impact, for papers by Paul J. Simpson Breakdown of academic impact, for papers by Kathleen F. Kerr Breakdown of academic impact, for papers by Chang Yu Breakdown of academic impact, for papers by Wolfgang Lieb Breakdown of academic impact, for papers by Scott J. Cameron Breakdown of academic impact, for papers by Amy P. Hsu